Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

<p>Abstract</p> <p>Background</p> <p>In recent years inhibitors directed against the epidermal growth factor receptor (EGFR) have evolved as effective targeting cancer drugs. Characteristic papulopustular exanthemas, often described as acneiform rashes, are the most fre...

Full description

Bibliographic Details
Main Authors: Gerber Peter, Meller Stephan, Eames Tatiana, Buhren Bettina, Schrumpf Holger, Hetzer Sonja, Ehmann Laura, Budach Wilfried, Bölke Edwin, Matuschek Christiane, Wollenberg Andreas, Homey Bernhard
Format: Article
Language:English
Published: BMC 2012-02-01
Series:European Journal of Medical Research
Subjects:
EGFR
rash
papulopustular exanthema
erlotinib
cetuximab
panitumumab
gefitinib
Online Access:http://www.eurjmedres.com/content/17/1/4

Internet

http://www.eurjmedres.com/content/17/1/4

Similar Items